Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Ameris Bancorp downgraded to Market Perform from Outperform at Raymond James » 10:13
10/31/22
10/31
10:13
10/31/22
10:13
ABCB

Ameris Bancorp

$51.00 /

-0.77 (-1.49%)

Raymond James analyst…

Raymond James analyst David Feaster downgraded Ameris Bancorp to Market Perform from Outperform without a price target. Ameris Bancorp's Q3 results were better than expected, where core trends generally remain favorable, and the stock price has finally caught up with the strong fundamental performance of the bank, Feaster tells investors in a research note.

ShowHide Related Items >><<
ABCB Ameris Bancorp
$51.00 /

-0.77 (-1.49%)

ABCB Ameris Bancorp
$51.00 /

-0.77 (-1.49%)

10/31/22 Truist
Ameris Bancorp price target raised to $60 from $55 at Truist
10/31/22 Raymond James
Ameris Bancorp downgraded to Market Perform from Outperform at Raymond James
09/14/22 Truist
Ameris Bancorp price target raised to $55 from $52 at Truist
12/30/21 Stephens
Ameris Bancorp price target raised to $57 for Balboa deal at Stephens
ABCB Ameris Bancorp
$51.00 /

-0.77 (-1.49%)

Recommendations
Ameris Bancorp price target raised to $60 from $55 at Truist » 07:40
10/31/22
10/31
07:40
10/31/22
07:40
ABCB

Ameris Bancorp

$51.81 /

+0.55 (+1.07%)

Truist analyst Jennifer…

Truist analyst Jennifer Demba raised the firm's price target on Ameris Bancorp to $60 from $55 and keeps a Buy rating on the shares. The analyst cites the company's higher spread income, lower expenses, and lower provisioning being offset by lower fee income. Demba is cutting her FY22 EPS view on Ameris however to $4.90 from $5.14 and her FY23 view to $5.32 from $5.57, noting that its net interest margin expansion should be slowing in future periods as deposit pricing accelerates.

ShowHide Related Items >><<
ABCB Ameris Bancorp
$51.81 /

+0.55 (+1.07%)

ABCB Ameris Bancorp
$51.81 /

+0.55 (+1.07%)

10/31/22 Raymond James
Ameris Bancorp downgraded to Market Perform from Outperform at Raymond James
09/14/22 Truist
Ameris Bancorp price target raised to $55 from $52 at Truist
12/30/21 Stephens
Ameris Bancorp price target raised to $57 for Balboa deal at Stephens
ABCB Ameris Bancorp
$51.81 /

+0.55 (+1.07%)

Downgrade
Ameris Bancorp downgraded to Market Perform from Outperform at Raymond James » 05:03
10/31/22
10/31
05:03
10/31/22
05:03
ABCB

Ameris Bancorp

$51.81 /

+0.55 (+1.07%)

Raymond James analyst…

Raymond James analyst David Feaster downgraded Ameris Bancorp to Market Perform from Outperform without a price target.

ShowHide Related Items >><<
ABCB Ameris Bancorp
$51.81 /

+0.55 (+1.07%)

ABCB Ameris Bancorp
$51.81 /

+0.55 (+1.07%)

09/14/22 Truist
Ameris Bancorp price target raised to $55 from $52 at Truist
12/30/21 Stephens
Ameris Bancorp price target raised to $57 for Balboa deal at Stephens
ABCB Ameris Bancorp
$51.81 /

+0.55 (+1.07%)

Hot Stocks
Ameris Bancorp says focused on long-term growth in TBV » 09:03
10/28/22
10/28
09:03
10/28/22
09:03
ABCB

Ameris Bancorp

$51.27 /

+0.21 (+0.41%)

Says TBV has grown 10%…

Says TBV has grown 10% annualized over past five years. Says well positioned to be asset sensitive in rising rate environment. Says gain on sale margins expected to remain compressed until interest rate environment normalizes. Says origination product expected to return to pre-pandemic levels of $5B-$7B in 2022. Says purchase percentage returning closer to normal levels. Says well positioned for rising rate environment. Comments taken from Q3 investor presentation slides.

ShowHide Related Items >><<
ABCB Ameris Bancorp
$51.27 /

+0.21 (+0.41%)

09/14/22 Truist
Ameris Bancorp price target raised to $55 from $52 at Truist
12/30/21 Stephens
Ameris Bancorp price target raised to $57 for Balboa deal at Stephens
ABCB Ameris Bancorp
$51.27 /

+0.21 (+0.41%)

Earnings
Ameris Bancorp reports Q3 adjusted EPS $1.32, consensus $1.33 » 16:15
10/27/22
10/27
16:15
10/27/22
16:15
ABCB

Ameris Bancorp

$51.27 /

+0.21 (+0.41%)

Reports Q3 revenue…

Reports Q3 revenue $278.3M, consensus $276.22M. CEO Palmer Proctor said, "We had an outstanding Q3 where we saw significant expansion in our margin to 3.97%, continued improvement in our efficiency ratio to just over 50%, strengthening in our balance sheet and earning asset mix and tangible book value growth of more than 10%, annualized. I am proud of the work our team has done and this quarter's solid results. We remain focused on core fundamentals. Our momentum and discipline have positioned us well for the remainder of this year and for entering 2023."

ShowHide Related Items >><<
ABCB Ameris Bancorp
$51.27 /

+0.21 (+0.41%)

09/14/22 Truist
Ameris Bancorp price target raised to $55 from $52 at Truist
12/30/21 Stephens
Ameris Bancorp price target raised to $57 for Balboa deal at Stephens
ABCB Ameris Bancorp
$51.27 /

+0.21 (+0.41%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:04
10/27/22
10/27
10:04
10/27/22
10:04
NOW

ServiceNow

$423.51 /

+57.83 (+15.81%)

, MSFT

Microsoft

$229.14 /

-1.53 (-0.66%)

, TER

Teradyne

$81.46 /

-0.78 (-0.95%)

, PDD

Pinduoduo

$52.84 /

-0.265 (-0.50%)

, RNST

Renasant

$37.17 /

+1.6 (+4.50%)

, MEDP

Medpace

$217.50 /

-4.205 (-1.90%)

, META

Meta Platforms

$100.57 /

-29.26 (-22.54%)

, STX

Seagate

$52.32 /

-1.04 (-1.95%)

, VFC

VF Corp.

$27.97 /

-0.22 (-0.78%)

, TMO

Thermo Fisher

$498.59 /

-3.9 (-0.78%)

, SLAB

Silicon Labs

$111.29 /

-6.55 (-5.56%)

, MRCY

Mercury Systems

$49.00 /

+0.755 (+1.56%)

, IDYA

Ideaya Biosciences

$16.83 /

+0.58 (+3.57%)

, ACLX

Arcellx

$20.28 /

+0.02 (+0.10%)

, FEAM

5E Advanced Metals

$12.22 /

+ (+0.00%)

, ROIV

Roivant Sciences

$4.94 /

+0.11 (+2.28%)

Institutional investors…

ShowHide Related Items >><<
VFC VF Corp.
$27.97 /

-0.22 (-0.78%)

TMO Thermo Fisher
$498.59 /

-3.9 (-0.78%)

TER Teradyne
$81.46 /

-0.78 (-0.95%)

STX Seagate
$52.32 /

-1.04 (-1.95%)

SLAB Silicon Labs
$111.29 /

-6.55 (-5.56%)

ROIV Roivant Sciences
$4.94 /

+0.11 (+2.28%)

PDD Pinduoduo
$52.84 /

-0.265 (-0.50%)

NOW ServiceNow
$423.51 /

+57.83 (+15.81%)

MSFT Microsoft
$229.14 /

-1.53 (-0.66%)

MRCY Mercury Systems
$49.00 /

+0.755 (+1.56%)

META Meta Platforms
$100.57 /

-29.26 (-22.54%)

MEDP Medpace
$217.50 /

-4.205 (-1.90%)

IDYA Ideaya Biosciences
$16.83 /

+0.58 (+3.57%)

FEAM 5E Advanced Metals
$12.22 /

+ (+0.00%)

ACLX Arcellx
$20.28 /

+0.02 (+0.10%)

NOW ServiceNow
$423.51 /

+57.83 (+15.81%)

10/27/22 Truist
ServiceNow price target lowered to $525 from $550 at Truist
10/27/22 Cowen
ServiceNow price target raised to $520 from $510 at Cowen
10/27/22 Morgan Stanley
ServiceNow price target lowered to $520 from $540 at Morgan Stanley
10/27/22 Mizuho
ServiceNow price target raised to $500 from $480 at Mizuho
MSFT Microsoft
$229.14 /

-1.53 (-0.66%)

10/27/22 Jefferies
Meta commentary positive for datacenter semi names, says Jefferies
10/27/22 MoffettNathanson
ServiceNow upgraded to Outperform from Market Perform at MoffettNathanson
10/26/22 RBC Capital
Microsoft price target lowered to $310 from $380 at RBC Capital
10/26/22 BMO Capital
Microsoft price target lowered to $270 from $295 at BMO Capital
TER Teradyne
$81.46 /

-0.78 (-0.95%)

10/27/22 DA Davidson
Teradyne price target lowered to $105 from $120 at DA Davidson
10/27/22 Craig-Hallum
Craig-Hallum upgrades Teradyne to Buy with $120 price target
10/27/22 Susquehanna
Teradyne price target raised to $100 from $83 at Susquehanna
10/27/22 Craig-Hallum
Teradyne upgraded to Buy from Hold at Craig-Hallum
PDD Pinduoduo
$52.84 /

-0.265 (-0.50%)

10/27/22 Citi
Citi opens 'positive catalyst watch' on Pinduoduo into Q3 report
10/27/22 Barclays
Pinduoduo upgraded to Overweight from Equal Weight at Barclays
09/02/22 Barclays
Pinduoduo price target raised to $66 from $45 at Barclays
08/31/22 Macquarie
Pinduoduo price target raised to $104 from $77 at Macquarie
RNST Renasant
$37.17 /

+1.6 (+4.50%)

10/27/22 Raymond James
Renasant upgraded to Outperform from Market Perform at Raymond James
10/27/22 Raymond James
Renasant upgraded to Outperform from Market Perform at Raymond James
08/01/22 Truist
Renasant price target raised to $35 from $31 at Truist
06/21/22 Hovde Group
Renasant upgraded to Outperform from Market Perform at Hovde Group
MEDP Medpace
$217.50 /

-4.205 (-1.90%)

10/27/22 UBS
Medpace upgraded to Neutral from Sell at UBS
10/26/22 Baird
Medpace price target raised to $217 from $200 at Baird
10/25/22 Baird
Medpace price target raised to $200 from $145 at Baird
09/07/22 UBS
Medpace initiated with a Sell at UBS
META Meta Platforms
$100.57 /

-29.26 (-22.54%)

10/27/22 Huber Research
Meta Platforms downgraded to Underweight from Overweight at Huber Research
10/27/22 RBC Capital
Meta Platforms price target lowered to $150 from $190 at RBC Capital
10/27/22 MKM Partners
Meta Platforms price target lowered to $140 from $195 at MKM Partners
STX Seagate
$52.32 /

-1.04 (-1.95%)

10/27/22 Northland
Seagate price target lowered to $70 from $88 at Northland
10/27/22 Deutsche Bank
Seagate price target lowered to $55 from $60 at Deutsche Bank
10/27/22 Mizuho
Seagate price target lowered to $62 from $75 at Mizuho
10/27/22 Susquehanna
Seagate price target lowered to $38 from $40 at Susquehanna
VFC VF Corp.
$27.97 /

-0.22 (-0.78%)

10/27/22 Wedbush
VF Corp. price target lowered to $29 from $35 at Wedbush
10/27/22 JPMorgan
VF downgraded to Underweight with $29 target at JPMorgan
10/27/22 Baird
VF Corp. price target lowered to $40 from $45 at Baird
10/27/22 Credit Suisse
VF Corp. price target lowered to $36 from $45 at Credit Suisse
TMO Thermo Fisher
$498.59 /

-3.9 (-0.78%)

10/27/22 Morgan Stanley
Thermo Fisher price target lowered to $613 from $678 at Morgan Stanley
10/27/22 Baird
Thermo Fisher price target lowered to $696 from $711 at Baird
10/27/22 Citi
Thermo Fisher price target lowered to $650 from $715 at Citi
10/27/22 Benchmark
Thermo Fisher downgraded to Hold from Buy at Benchmark
SLAB Silicon Labs
$111.29 /

-6.55 (-5.56%)

10/27/22 Cowen
Silicon Labs price target lowered to $150 from $175 at Cowen
10/27/22 Barclays
Silicon Labs price target lowered to $85 from $95 at Barclays
10/27/22 Needham
Silicon Labs downgraded on consumer demand risk at Needham
10/27/22 Needham
Silicon Labs downgraded to Hold from Buy at Needham
MRCY Mercury Systems
$49.00 /

+0.755 (+1.56%)

10/27/22 Raymond James
Mercury Systems initiated with an Outperform at Raymond James
08/03/22 Alembic Global
Mercury Systems downgraded to Neutral from Overweight at Alembic Global
08/03/22 Baird
Mercury Systems price target lowered to $58 from $72 at Baird
05/31/22 Baird
Baird upgrades Mercury Systems to Outperform with visibility set to improve
IDYA Ideaya Biosciences
$16.83 /

+0.58 (+3.57%)

10/27/22 Citi
Ideaya Biosciences initiated with a Buy at Citi
09/13/22 Guggenheim
Ideaya Biosciences price target raised to $32 from $20 at Guggenheim
08/16/22 Baird
Ideaya Biosciences price target lowered to $18 from $26 at Baird
08/16/22 Oppenheimer
Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
ACLX Arcellx
$20.28 /

+0.02 (+0.10%)

10/27/22 Needham
Arcellx initiated with a Buy at Needham
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Canaccord
Arcellx initiated with a Buy at Canaccord
03/02/22 Barclays
Arcellx initiated with an Overweight at Barclays
FEAM 5E Advanced Metals
$12.22 /

+ (+0.00%)

10/27/22 B. Riley
5E Advanced Metals initiated with a Buy at B. Riley
10/06/22 Baird
5E Advanced Metals price target lowered to $21 from $36 at Baird
06/09/22 Baird
Baird starts 5E Advanced Metals at Outperform, sees opportunity for market gains
06/09/22 Baird
5E Advanced Metals initiated with an Outperform at Baird
ROIV Roivant Sciences
$4.94 /

+0.11 (+2.28%)

10/27/22 JPMorgan
Roivant Sciences initiated with an Overweight at JPMorgan
08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
VFC VF Corp.
$27.97 /

-0.22 (-0.78%)

TMO Thermo Fisher
$498.59 /

-3.9 (-0.78%)

TER Teradyne
$81.46 /

-0.78 (-0.95%)

STX Seagate
$52.32 /

-1.04 (-1.95%)

SLAB Silicon Labs
$111.29 /

-6.55 (-5.56%)

ROIV Roivant Sciences
$4.94 /

+0.11 (+2.28%)

RNST Renasant
$37.17 /

+1.6 (+4.50%)

PDD Pinduoduo
$52.84 /

-0.265 (-0.50%)

NOW ServiceNow
$423.51 /

+57.83 (+15.81%)

MSFT Microsoft
$229.14 /

-1.53 (-0.66%)

MRCY Mercury Systems
$49.00 /

+0.755 (+1.56%)

META Meta Platforms
$100.57 /

-29.26 (-22.54%)

MEDP Medpace
$217.50 /

-4.205 (-1.90%)

IDYA Ideaya Biosciences
$16.83 /

+0.58 (+3.57%)

ACLX Arcellx
$20.28 /

+0.02 (+0.10%)

  • 15
    Sep
  • 17
    Jun
  • 04
    Feb
TER Teradyne
$81.46 /

-0.78 (-0.95%)

PDD Pinduoduo
$52.84 /

-0.265 (-0.50%)

MSFT Microsoft
$229.14 /

-1.53 (-0.66%)

MRCY Mercury Systems
$49.00 /

+0.755 (+1.56%)

META Meta Platforms
$100.57 /

-29.26 (-22.54%)

VFC VF Corp.
$27.97 /

-0.22 (-0.78%)

TMO Thermo Fisher
$498.59 /

-3.9 (-0.78%)

TER Teradyne
$81.46 /

-0.78 (-0.95%)

STX Seagate
$52.32 /

-1.04 (-1.95%)

ROIV Roivant Sciences
$4.94 /

+0.11 (+2.28%)

PDD Pinduoduo
$52.84 /

-0.265 (-0.50%)

NOW ServiceNow
$423.51 /

+57.83 (+15.81%)

MSFT Microsoft
$229.14 /

-1.53 (-0.66%)

MRCY Mercury Systems
$49.00 /

+0.755 (+1.56%)

META Meta Platforms
$100.57 /

-29.26 (-22.54%)

MEDP Medpace
$217.50 /

-4.205 (-1.90%)

IDYA Ideaya Biosciences
$16.83 /

+0.58 (+3.57%)

ACLX Arcellx
$20.28 /

+0.02 (+0.10%)

VFC VF Corp.
$27.97 /

-0.22 (-0.78%)

TMO Thermo Fisher
$498.59 /

-3.9 (-0.78%)

TER Teradyne
$81.46 /

-0.78 (-0.95%)

STX Seagate
$52.32 /

-1.04 (-1.95%)

PDD Pinduoduo
$52.84 /

-0.265 (-0.50%)

NOW ServiceNow
$423.51 /

+57.83 (+15.81%)

MSFT Microsoft
$229.14 /

-1.53 (-0.66%)

META Meta Platforms
$100.57 /

-29.26 (-22.54%)

FEAM 5E Advanced Metals
$12.22 /

+ (+0.00%)

ACLX Arcellx
$20.28 /

+0.02 (+0.10%)

Upgrade
Renasant upgraded to Outperform from Market Perform at Raymond James » 06:31
10/27/22
10/27
06:31
10/27/22
06:31
RNST

Renasant

$35.57 /

+0.46 (+1.31%)

Raymond James analyst…

Raymond James analyst Michael Rose upgraded Renasant to Outperform from Market Perform with a $41 price target. Renasant's Q3 results exceeded expectations on a core basis, and Rose's now positive bias fits the view that the company/stock reflects its conservative lending culture and expectations for better than peer through the cycle loss content, strong low-cost core deposit base that should result in lower costs/betas than most peers/the industry, solid capital position, and strong loan loss reserves, the analyst tells investors in a research note. Rose also views the achievement of its sub 60% efficiency target and the now largely-absorbed headwinds from strong mortgage contribution early in the pandemic as a notable inflection point.

ShowHide Related Items >><<
RNST Renasant
$35.57 /

+0.46 (+1.31%)

10/27/22 Raymond James
Renasant upgraded to Outperform from Market Perform at Raymond James
08/01/22 Truist
Renasant price target raised to $35 from $31 at Truist
06/21/22 Hovde Group
Renasant upgraded to Outperform from Market Perform at Hovde Group
06/15/22 Truist
Renasant price target lowered to $31 from $33 at Truist
RNST Renasant
$35.57 /

+0.46 (+1.31%)

Upgrade
Renasant upgraded to Outperform from Market Perform at Raymond James » 05:01
10/27/22
10/27
05:01
10/27/22
05:01
RNST

Renasant

$35.57 /

+0.46 (+1.31%)

Raymond James analyst…

Raymond James analyst Michael Rose upgraded Renasant to Outperform from Market Perform with a $41 price target.

ShowHide Related Items >><<
RNST Renasant
$35.57 /

+0.46 (+1.31%)

08/01/22 Truist
Renasant price target raised to $35 from $31 at Truist
06/21/22 Hovde Group
Renasant upgraded to Outperform from Market Perform at Hovde Group
06/15/22 Truist
Renasant price target lowered to $31 from $33 at Truist
02/24/22 DA Davidson
Renasant upgraded to Buy from Neutral at DA Davidson
RNST Renasant
$35.57 /

+0.46 (+1.31%)

Earnings
Renasant reports Q3 EPS 83c, consensus 77c » 16:39
10/25/22
10/25
16:39
10/25/22
16:39
RNST

Renasant

$35.12 /

+0.045 (+0.13%)

Reports Q3 tangible book…

Reports Q3 tangible book value per share $20.12. Reports Q3 CET1 capital ratio 10.64%. Reports Q3 net charge-offs .06%. "Results for the third quarter reflect continued improvement in profitability. Earnings benefited from expansion in the net interest margin, effective expense management and solid organic loan growth," remarked C. Mitchell Waycaster, Renasant president and CEO. "The balance sheet remains sound, with a solid base of core deposits, continued good asset quality and strong capital levels."

ShowHide Related Items >><<
RNST Renasant
$35.12 /

+0.045 (+0.13%)

08/01/22 Truist
Renasant price target raised to $35 from $31 at Truist
06/21/22 Hovde Group
Renasant upgraded to Outperform from Market Perform at Hovde Group
06/15/22 Truist
Renasant price target lowered to $31 from $33 at Truist
02/24/22 DA Davidson
Renasant upgraded to Buy from Neutral at DA Davidson
RNST Renasant
$35.12 /

+0.045 (+0.13%)

On The Fly
Fly Intel: After-Hours Movers » 18:53
10/24/22
10/24
18:53
10/24/22
18:53
MEDP

Medpace

$158.72 /

+1.84 (+1.17%)

, XM

Qualtrics

$10.46 /

-0.105 (-0.99%)

, CLS

Celestica

$9.53 /

+0.275 (+2.97%)

, FLXS

Flexsteel Industries

$13.83 /

-0.04 (-0.29%)

, SSB

South State

$85.79 /

+0.23 (+0.27%)

, CDNS

Cadence Design

$160.20 /

+1.82 (+1.15%)

, ADTN

Adtran

$19.30 /

+0.22 (+1.15%)

, CCK

Crown Holdings

$84.98 /

+1.075 (+1.28%)

, HSII

Heidrick & Struggles

$28.63 /

-0.28 (-0.97%)

, ZION

Zions Bancorp

$49.80 /

+2.02 (+4.23%)

, CR

Crane

$99.76 /

-0.175 (-0.18%)

, WRB

W. R. Berkley

$72.55 /

+1.34 (+1.88%)

, TBI

TrueBlue

$21.68 /

-0.18 (-0.82%)

, DFS

Discover

$95.80 /

+1.13 (+1.19%)

, BRO

Brown & Brown

$63.11 /

+1.485 (+2.41%)

Check out this evening's…

ShowHide Related Items >><<
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

SSB South State
$85.79 /

+0.23 (+0.27%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CR Crane
$99.76 /

-0.175 (-0.18%)

CLS Celestica
$9.53 /

+0.275 (+2.97%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

CCK Crown Holdings
$84.98 /

+1.075 (+1.28%)

BRO Brown & Brown
$63.11 /

+1.485 (+2.41%)

ADTN Adtran
$19.30 /

+0.22 (+1.15%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

09/07/22 UBS
Medpace initiated with a Sell at UBS
05/23/22 Guggenheim
Medpace initiated with Neutral on pre-revenue focus at Guggenheim
05/23/22 Guggenheim
Medpace initiated with a Neutral at Guggenheim
03/17/22 Baird
Medpace price target raised to $175 from $160 at Baird
XM Qualtrics
$10.46 /

-0.105 (-0.99%)

10/19/22 Morgan Stanley
Qualtrics price target lowered to $14 from $17 at Morgan Stanley
10/18/22 Barclays
Qualtrics price target lowered to $11 from $16 at Barclays
10/03/22 Exane BNP Paribas
Qualtrics upgraded to Outperform from Neutral at Exane BNP Paribas
08/09/22 HSBC
Qualtrics price target lowered to $20 from $40 at HSBC
CLS Celestica
$9.53 /

+0.275 (+2.97%)

08/18/22 Argus
Celestica upgraded to Buy at Argus amid strong year-to-date results
08/18/22 Argus
Celestica upgraded to Buy from Hold at Argus
07/27/22 BMO Capital
Celestica upgraded to Outperform from Market Perform at BMO Capital
07/27/22 Canaccord
Celestica positioned well despite headwinds, says Canaccord
FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

SSB South State
$85.79 /

+0.23 (+0.27%)

09/28/22 Piper Sandler
South State upgraded to Overweight from Neutral at Piper Sandler
08/01/22 Truist
South State price target raised to $97 from $90 at Truist
06/15/22 Truist
South State price target lowered to $90 from $92 at Truist
06/02/22 Keefe Bruyette
South State upgraded to Outperform from Market Perform at Keefe Bruyette
CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

10/24/22 Rosenblatt
Cadence Design price target lowered to $175 from $185 at Rosenblatt
09/29/22 Deutsche Bank
Cadence Design initiated with a Buy at Deutsche Bank
09/07/22 Stifel
Stifel starts Cadence Design at Hold, prefers Synopsys on valuation basis
09/07/22 Stifel
Cadence Design initiated with a Hold at Stifel
ADTN Adtran
$19.30 /

+0.22 (+1.15%)

09/26/22 Loop Capital
Adtran upgraded to Buy from Hold at Loop Capital
09/26/22 Loop Capital
Adtran upgraded to Buy from Hold at Loop Capital
09/13/22 WestPark Capital
Adtran initiated with a Hold at WestPark Capital
07/14/22 Needham
Adtran initiated with a Buy at Needham
CCK Crown Holdings
$84.98 /

+1.075 (+1.28%)

10/24/22 Deutsche Bank
Crown Holdings price target lowered to $109 from $115 at Deutsche Bank
10/24/22 Mizuho
Crown Holdings price target lowered to $112 from $124 at Mizuho
10/14/22 RBC Capital
Crown Holdings price target lowered to $110 from $122 at RBC Capital
10/13/22 BofA
Crown Holdings price target lowered to $105 from $106 at BofA
HSII Heidrick & Struggles
$28.63 /

-0.28 (-0.97%)

07/28/22 Barrington
Heidrick & Struggles price target lowered to $45 from $54 at Barrington
07/15/22 Truist
Heidrick & Struggles price target lowered to $30 from $50 at Truist
04/27/22 Barrington
Heidrick & Struggles price target raised to $54 from $50 at Barrington
10/28/21 Barrington
Heidrick & Struggles price target raised to $53 from $50 at Barrington
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

10/06/22 Keefe Bruyette
KBW recommends pair trade of overweight Comerica, underweight Zions
10/06/22 Keefe Bruyette
Keefe Bruyette downgrades Zions to Market Perform into Q3 results
10/06/22 Keefe Bruyette
Zions Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
09/28/22 Wedbush
Zions Bancorp assumed with a Neutral at Wedbush
CR Crane
$99.76 /

-0.175 (-0.18%)

10/11/22 Stifel
Crane price target lowered to $121 from $123 at Stifel
04/18/22 Stifel
Crane price target lowered to $134 from $137 at Stifel
12/03/21 Morgan Stanley
Crane initiated with an Equal Weight at Morgan Stanley
10/26/21 DA Davidson
Crane price target raised to $125 from $115 at DA Davidson
WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

09/05/22 Keefe Bruyette
W. R. Berkley upgraded to Outperform from Market Perform at Keefe Bruyette
08/03/22 Argus
W. R. Berkley initiated with a Buy at Argus
08/03/22 Argus
W. R. Berkley initiated with a Buy at Argus
07/12/22 Jefferies
W. R. Berkley price target raised to $70 from $67 at Jefferies
TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

07/26/22 Baird
TrueBlue price target lowered to $28 from $36 at Baird
05/26/22 BMO Capital
TrueBlue downgraded to Market Perform from Outperform at BMO Capital
04/11/22 Sidoti
TrueBlue reinstated with a Buy at Sidoti
10/26/21 Baird
TrueBlue price target raised to $35 from $31 at Baird
DFS Discover
$95.80 /

+1.13 (+1.19%)

10/13/22 Citi
Discover price target lowered to $103 from $115 at Citi
10/13/22 Barclays
Discover price target lowered to $115 from $133 at Barclays
09/26/22 Piper Sandler
Discover price target lowered to $124 from $132 at Piper Sandler
09/06/22 JPMorgan
Discover downgraded on more cautious consumer outlook at JPMorgan
BRO Brown & Brown
$63.11 /

+1.485 (+2.41%)

10/07/22 Jefferies
Brown & Brown price target raised to $74 from $70 at Jefferies
07/27/22 RBC Capital
Brown & Brown price target lowered to $66 from $71 at RBC Capital
07/18/22 Truist
Brown & Brown price target lowered to $75 from $82 at Truist
07/12/22 Jefferies
Brown & Brown price target lowered to $70 from $82 at Jefferies
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

SSB South State
$85.79 /

+0.23 (+0.27%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

HSII Heidrick & Struggles
$28.63 /

-0.28 (-0.97%)

FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CR Crane
$99.76 /

-0.175 (-0.18%)

CLS Celestica
$9.53 /

+0.275 (+2.97%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

CCK Crown Holdings
$84.98 /

+1.075 (+1.28%)

BRO Brown & Brown
$63.11 /

+1.485 (+2.41%)

ADTN Adtran
$19.30 /

+0.22 (+1.15%)

  • 05
    Nov
ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

WRB W. R. Berkley
$72.55 /

+1.34 (+1.88%)

TBI TrueBlue
$21.68 /

-0.18 (-0.82%)

SSB South State
$85.79 /

+0.23 (+0.27%)

MEDP Medpace
$158.72 /

+1.84 (+1.17%)

FLXS Flexsteel Industries
$13.83 /

-0.04 (-0.29%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

ADTN Adtran
$19.30 /

+0.22 (+1.15%)

ZION Zions Bancorp
$49.80 /

+2.02 (+4.23%)

XM Qualtrics
$10.46 /

-0.105 (-0.99%)

DFS Discover
$95.80 /

+1.13 (+1.19%)

CDNS Cadence Design
$160.20 /

+1.82 (+1.15%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.